CYTOMEGALOVIRUS (CMV) INFECTION
Clinical trials for CYTOMEGALOVIRUS (CMV) INFECTION explained in plain language.
Never miss a new study
Get alerted when new CYTOMEGALOVIRUS (CMV) INFECTION trials appear
Sign up with your email to follow new studies for CYTOMEGALOVIRUS (CMV) INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New kidney treatment aims to stop hidden virus from infecting transplant patients
Disease control Not yet recruitingThis early safety trial tests a treatment called SYN002 on donor kidneys before transplant. The goal is to lower the risk of passing the common CMV virus from the donor organ to the recipient. About 12 adults waiting for a kidney transplant will take part. The main focus is wheth…
Matched conditions: CYTOMEGALOVIRUS (CMV) INFECTION
Phase: EARLY_PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 26, 2026 10:16 UTC
-
Could this old drug save lives in advanced HIV?
Disease control Not yet recruitingThis study tests whether the antiviral drug valganciclovir can safely reduce CMV virus levels in the blood of people with advanced HIV (CD4 count 100 or less). About 130 adults and adolescents in South Africa and Uganda will receive either the drug or a placebo daily for 4 weeks,…
Matched conditions: CYTOMEGALOVIRUS (CMV) INFECTION
Phase: PHASE2 • Sponsor: Wits Health Consortium (Pty) Ltd • Aim: Disease control
Last updated May 26, 2026 10:10 UTC